Jamie Triccas is a bacteriologist who uses a multidisciplinary approach to define immunity to chronic bacterial pathogens and develop new treatments to control infection. He is a Professor of Medical Microbiology and Deputy Director of the Sydney Institute Infectious Diseases (Sydney ID) at the University of Sydney. He has over 30 years’ experience working with clinically important pathogens and has published widely on aspects of bacterial pathogenesis, immunity to infection and vaccine development/testing. His team has progressed multiple vaccine candidates from discovery through to preclinical readiness, including a CEPI-funded broadly protective coronavirus vaccine that will soon enter clinical trials. He provides scientific and program leadership across national and international collaborations involving academia, industry and global health organisations.